Howard Lee - 07 Jun 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
07 Jun 2021
Transactions value $
-$45,412
Form type
4
Filing time
08 Jun 2021, 20:56:23 UTC
Previous filing
24 May 2021
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $129K +7.83K +5.89% $16.43 141K 07 Jun 2021 Direct
transaction AMPH Common Stock Sale -$151K -7.83K -5.56% $19.28 133K 07 Jun 2021 Direct F1
transaction AMPH Common Stock Award $0 +6.02K +4.53% $0.00 139K 07 Jun 2021 Direct F2
transaction AMPH Common Stock Options Exercise $131K +8K +5.76% $16.43 147K 08 Jun 2021 Direct
transaction AMPH Common Stock Sale -$155K -8K -5.44% $19.31 139K 08 Jun 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Disposed to Issuer $0 -7.83K -49.45% $0.00 8K 07 Jun 2021 Common Stock 7.83K $16.43 Direct F4
transaction AMPH Stock Option (right to buy) Award $0 +17.2K $0.00 17.2K 07 Jun 2021 Common Stock 17.2K $19.52 Direct F5
transaction AMPH Stock Option (right to buy) Disposed to Issuer $0 -8K -100% $0.00* 0 08 Jun 2021 Common Stock 8K $16.43 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.20 to $19.40 shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
F2 The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 7, 2022.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.30 to $19.353, inclusive.
F4 Shares subject to the option are fully vested and immediately exercisable.
F5 All of the shares subject to the option vest on June 7, 2022.